On October 5, 2021, the Office of the United States Trade Representative (USTR) issued a Notice and Request for Comments to consider the reinstatement of expired product exclusions from the China Section 301 tariffs. The USTR...more
10/8/2021
/ China ,
Comment Period ,
Coronavirus/COVID-19 ,
Exclusions ,
Imports ,
Section 301 ,
Supply Chain ,
Tariffs ,
Trade Relations ,
US Trade Policies ,
USTR
On 5 May 2021, U.S. Trade Representative Katherine Tai announced that the Biden Administration would support India and South Africa’s request for a World Trade Organization (WTO) waiver of intellectual property (IP) rights...more
5/12/2021
/ Biden Administration ,
Coronavirus/COVID-19 ,
Infectious Diseases ,
Intellectual Property Protection ,
Life Sciences ,
Patent Ownership ,
Pharmaceutical Industry ,
Popular ,
TRIPS Agreement ,
Vaccinations ,
WTO
On Tuesday, November 3, 2020, Americans chose the presidency and the makeup of the United States Congress. With the U.S. election now decided, with the exception of the Georgia Senate races, we are delighted to share with you...more
12/29/2020
/ 5G Network ,
Antitrust Provisions ,
Biden Administration ,
CFIUS ,
Coronavirus/COVID-19 ,
Foreign Investment ,
Healthcare Reform ,
Infectious Diseases ,
Infrastructure ,
Presidential Elections ,
Public Transportation ,
Regulatory Reform ,
Tax Reform
On November 19, leaders of our Life Sciences and Health Care team met for a panel discussion of the impacts on the industry of the 2020 U.S. election. This was the first event in a series of conversations, with other webinars...more
12/1/2020
/ Affordable Care Act ,
Biden Administration ,
Biotechnology ,
China ,
Coronavirus/COVID-19 ,
Drug Pricing ,
FDA Approval ,
Healthcare Reform ,
Infectious Diseases ,
Life Sciences ,
Operation Warp Speed ,
Presidential Elections ,
Trans-Pacific Partnership ,
US Trade Policies ,
Vaccinations
President-elect Joe Biden has pledged to expand the role of the federal government in response to the COVID-19 public health emergency, build on the Affordable Care Act, and continue drug pricing reform efforts. These actions...more
Life Sciences and Health Care Horizons virtual event series -
The fast pace of innovation in the life sciences and health care industry has reached an all-time high in 2020 as the industry grapples with the new reality of...more
11/9/2020
/ Affordable Care Act ,
Business Disruption ,
Coronavirus/COVID-19 ,
Drug Pricing ,
Emergency Use Authorization (EUA) ,
Federal Funding ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Health Insurance ,
Imports ,
Life Sciences ,
Medicaid ,
Medicare ,
Pharmaceutical Industry ,
Prescription Drugs ,
Presidential Elections ,
Public Health ,
Supply Chain ,
Trade Relations ,
Webinars
With an interim relief measure, the Paycheck Protection Program (PPP) and Health Care Enhancement Act, now signed into law, the jockeying over a CARES 2.0 stimulus package has begun. What follows is a thumbnail sketch of the...more
On 17 April the Federal Emergency Management Agency (FEMA) released significant exceptions (effective Friday 17 April, but to be published on 21 April) to FEMA's temporary final rule prohibiting exports of certain personal...more